Skip to content

Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial

Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial - Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041204
Enrollment
60
Registered
2020-07-24
Start date
2020-06-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

High performance shower head General shower head

Sponsors

Takashima Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Men and women over the age of 18 diagnosed with atopic dermatitis 2) Those who can only use the shower during the test period 3) Those who have agreed to take a picture of the affected area 4) Those who can install the shower head specified in the test 5) Can obtain written consent

Exclusion criteria

Exclusion criteria: 1) There are skin diseases other than atopic dermatitis such as burns 2) With tattoos and tattoos 3) May become pregnant during pregnancy or during the study period 4) Heart disease, cerebrovascular disease, arrhythmia, history of dizziness and being affected 5) Systolic blood pressure at screening is 170 mmHg or more or diastolic blood pressure is 110 mmHg or more. However, those taking antihypertensive drugs have systolic blood pressure of 150 mmHg or more. 6) May be in need of treatment during treatment or for malignant tumor 7) Surgical operation was performed within 6 months from the time of screening, or radiotherapy for malignant tumor. 8) The investigator determined that he was unsuitable as a researcher

Design outcomes

Primary

MeasureTime frame
Evaluation prescribed in "Atopic Dermatitis Practice Guideline 2018" established by the Japanese Dermatological Association

Countries

Japan

Contacts

Public ContactFumihiko Sato

Takashima Clinic Critical Research

f-sato@qolife.jp06-6606-9090

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026